SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-002815
Filing Date
2017-01-19
Accepted
2017-01-19 07:05:23
Documents
3
Period of Report
2017-01-13
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v457126_8k.htm 8-K 21432
2 EXHIBIT 99.1 v457126_ex99-1.htm EX-99.1 13626
3 GRAPHIC image_003.jpg GRAPHIC 3866
  Complete submission text file 0001144204-17-002815.txt   41710
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-193455 | Film No.: 17534814
SIC: 2834 Pharmaceutical Preparations